Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials

By Sam | February 6, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-Merck-KGaA-Germany.jpg" NAME"Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials" ALT"Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials"February 7, 2017By Mark Terry…
Source: BioSpace

Posted in BioPharma